Angola

Objectives

Build at Catumbela/Lobito the first pharmaceutical complex of the project, the pilot of the TSISSA Medicines model.

Progress

• Local company TSISSA Medicines Angola incorporated with its tax number.
• Official mission from 7 to 17 September 2026.
• Catumbela/Lobito site chosen as the priority.
• Land options identified.
• Interest expressed by several distributors.

Expected impact

• Import substitution.
• Skilled jobs.
• Training.
• Regional integration through the Lobito Corridor.

Agreements

No signed agreement publishable to date. The institutional MOU is in preparation and is not presented as signed.

Next steps

• Finalisation of the MOU.
• Written confirmation of the land.
• Feasibility studies.